Shares of Agilent Technologies Inc. A, -0.35% fell after hours on Tuesday after the laboratory-equipment maker cut its full-year outlook to reflect “increased market uncertainties” and issued a weaker-than-expected third-quarter forecast. The company said it expected full-year sales of $6.93 billion to $7.03 billion, compared to a prior forecast of $7.03 billion to $7.1 billion given in February. And it said it expected full-year adjusted earnings per share of $5.60 to $5.65, down from $5.65 to $5.70. Agilent said it expected third-quarter sales of $1.64 billion to $1.675 billion, below FactSet forecasts for $1.77 billion, and adjusted earnings per share of $1.36 to $1.38, below estimates for $1.43. Shares fell 6.9% after hours. For its fiscal second quarter, Agilent reported adjusted earnings per share of $1.27, above FactSet estimates for $1.26, on revenue of $1.72 billion, also topping estimates for $1.67 billion.
This article was originally published by Marketwatch.com. Read the original article here.
